The goal of the American Kidney Fund Clinical Scientist in Nephrology (CSN) fellowship program is to improve the quality of care provided to kidney patients and to promote clinical research in nephrology. The CSN program enhances the training of nephrologists who wish to pursue an academic career and whose primary professional commitment is to scholarship in the provision of patient care. Our CSN fellows conduct prevention and outcomes research while receiving advanced training in essential skills such as medical ethics, biostatistics and epidemiology.
The Clinical Scientist in Nephrology program was established in 1988, and since that time has trained some of nephrology's brightest scholars. Many former CSN fellows have gone on to distinguished careers in the field, conducting groundbreaking research that advances knowledge and treatment of kidney disease.
A Clinical Scientist in Nephrology fellowship may be granted yearly, with a maximum duration of two years for each fellowship. The maximum level of funding of $80,000 per year shall be used principally to support the candidate and his or her career development. This sum is expected to cover the individual fellow's salary (which will follow NIH guidelines according to the post-graduate year plus comparable fringe benefits at the institution, not to exceed $50,000) as well as training-related expenses.
The deadline for application submissions for the 2017-2018 academic year is December 1, 2016. For questions about the program, please email Ruth Flores.
Meet the current CSN fellows
Anoop Sheshadri, MD
Awarded the American Kidney Fund Clinical Scientist in Nephrology fellowship, a program funded by Amgen and Sanofi-Renal, Dr. Sheshadri is completing his renal fellowship at the University of California, San Francisco. Dr. Sheshadri’s research is titled “Pedometers and Exercise in Dialysis.” Some of the aims of his study are to determine whether a pedometer-based walking intervention will result in increased physical activity in patients treated with dialysis and to determine whether increases in physical activity in patients treated with dialysis will result in improved physical function and in endothelial function.
Year Fellowship Awarded: 2016
Megan Yanik, MD
Awarded the American Kidney Fund Clinical Scientist in Nephrology fellowship, a program funded by Amgen and Sanofi-Renal, Dr. Yanik is completing her fellowship in pediatric nephrology at the University of Alabama at Birmingham. Dr. Yanik’s project is titled “Pharmacogenomics of Tracolimus in Pediatric Kidney Transplant Recipients.” The aims of Dr. Yanik’s study are to determine the influence the CYP3A5 genotype has on the time to achieve a therapeutic level of tacrolimus in pediatric kidney transplant recipients and to determine the influence of CYP3A5 genotype on risk for acute rejection episodes in pediatric kidney transplant recipients.
Year Fellowship Awarded: 2016
John Stanifer, M.D., M.Sc.
Dr. John Stanifer is the American Kidney Fund-Amgen Clinical Scientist in Nephrology fellow. He completed his residency at Duke University where he is also now completing his renal fellowship. Dr. Stanifer's research aims to assess the health literacy of individuals with chronic kidney disease from an underserved community in southeastern North Carolina with a large American Indian and African American population. Read a post by Dr. Stanifer on our blog, Kidney Today.
Year Fellowship Awarded: 2015